Insiders · Profile

Dahl Andrew M.

SVP, Corporate Controller at Edwards Lifesciences. Filing since 29 May 2026. CIK 0002022347

Company
Date
Role
Action
Shares
Amount
Of holding
31 Aug 2026
SVP, Corporate Controller
Sold at will
544
$49.53K
3.5%
29 May 2026
SVP, Corporate Controller
Sold at will
568
$48.85K
3.6%
2 decisions on file.